SEC Form 4 · accession 0001136261-16-000687
PERNIX THERAPEUTICS HOLDINGS, INC. · PTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gabriel Leung
Director
Period of report
Nov 21, 2016
Accepted (ET)
Nov 22, 2016 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.50 | Nov 21, 2016 | A | 4,000 | A | — | Nov 20, 2026 | Common Stock | 4,000 | 4,000 | D |
Explanation of responses
- F1The stock option vests in annual installments of approximately 1,000 shares, commencing on the first anniversary of November 21, 2016, with the final installment vesting on the fourth anniversary of the vesting start date.